Cargando…
Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183775/ https://www.ncbi.nlm.nih.gov/pubmed/25238138 http://dx.doi.org/10.1038/bcj.2014.66 |
| _version_ | 1782337746708201472 |
|---|---|
| author | Maurizot, A Beressi, J-P Manéglier, B de la Marre, N H Spentchian, M Soury, P Solvet-Sebire, P Collet-Gaudillat, C Baud, J-M Livarek, B Guilhot, F Rousselot, P |
| author_facet | Maurizot, A Beressi, J-P Manéglier, B de la Marre, N H Spentchian, M Soury, P Solvet-Sebire, P Collet-Gaudillat, C Baud, J-M Livarek, B Guilhot, F Rousselot, P |
| author_sort | Maurizot, A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4183775 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41837752014-10-03 Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion Maurizot, A Beressi, J-P Manéglier, B de la Marre, N H Spentchian, M Soury, P Solvet-Sebire, P Collet-Gaudillat, C Baud, J-M Livarek, B Guilhot, F Rousselot, P Blood Cancer J Letter to the Editor Nature Publishing Group 2014-09 2014-09-19 /pmc/articles/PMC4183775/ /pubmed/25238138 http://dx.doi.org/10.1038/bcj.2014.66 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Letter to the Editor Maurizot, A Beressi, J-P Manéglier, B de la Marre, N H Spentchian, M Soury, P Solvet-Sebire, P Collet-Gaudillat, C Baud, J-M Livarek, B Guilhot, F Rousselot, P Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion |
| title | Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion |
| title_full | Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion |
| title_fullStr | Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion |
| title_full_unstemmed | Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion |
| title_short | Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion |
| title_sort | rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183775/ https://www.ncbi.nlm.nih.gov/pubmed/25238138 http://dx.doi.org/10.1038/bcj.2014.66 |
| work_keys_str_mv | AT maurizota rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT beressijp rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT maneglierb rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT delamarrenh rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT spentchianm rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT souryp rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT solvetsebirep rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT colletgaudillatc rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT baudjm rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT livarekb rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT guilhotf rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion AT rousselotp rapidclinicalimprovementofperipheralarteryocclusivediseasesymptomsafternilotinibdiscontinuationdespitepersistingvascularocclusion |